REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment. (2023)

First Author: Ghorani E

Attributed to: Method - Design funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(23)00095-5

PubMed Identifier: 37142383

Publication URI: http://europepmc.org/abstract/MED/37142383

Type: Journal Article/Review

Volume: 24

Parent Publication: The Lancet. Oncology

Issue: 5

ISSN: 1470-2045